GPNMB Protein

GPNMB Protein

Overview

Pathway Diagram

```mermaid
flowchart TD
GPNMB["GPNMB<br/>(Glycoprotein NMB)"]

%% Associated genes/proteins
APOE["APOE<br/>(Apolipoprotein E)"]
HMGB1["HMGB1<br/>(High Mobility Group<br/>Box 1 Protein)"]
NPTX2["NPTX2<br/>(Neuronal Pentraxin 2)"]

%% Pathways
Complement["Complement<br/>Pathway"]
Epigenetic["Epigenetic<br/>Regulation"]
Apoptosis["Apoptosis<br/>Pathway"]

%% Diseases - Protective
PD_protect["Parkinson's Disease<br/>(Protection)"]
ALS_protect["ALS<br/>(Protection)"]

%% Diseases - Associated/Biomarker
AD["Alzheimer's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]

%% Pathological processes
Inflammation["Neuroinflammation"]
Senescence["Cellular<br/>Senescence"]
Fibrosis["Tissue<br/>Fibrosis"]

%% Beneficial outcomes
Longevity["Longevity<br/>Promotion"]

%% Connections
GPNMB -->|"protects against"| PD_protect
GPNMB -->|"protects against"| ALS_protect
GPNMB -->|"biomarker for"| AD
GPNMB -->|"biomarker for"| MS
GPNMB -->|"activates"| Complement
GPNMB -->|"activates"| Epigenetic
GPNMB -->|"activates"| HMGB1
GPNMB -->|"associated with"| APOE
GPNMB -->|"associated with"| NPTX2
GPNMB -->|"biomarker for"| Inflammation
GPNMB -->|"biomarker for"| Senescence
GPNMB -->|"biomarker for"| Fibrosis
GPNMB -->|"biomarker for"| Longevity

Complement -->|"regulates"| Apoptosis
HMGB1 -->|"promotes"| Inflammation
Inflammation -->|"contributes to"| AD
Inflammation -->|"co

GPNMB Protein

Overview

Pathway Diagram

GPNMB protein (Glycoprotein Nonmetastatic Melanoma Protein B, also known as Osteoactivin or DC-HIL) is a type I transmembrane glycoprotein encoded by the [GPNMB](/genes/gpnmb) gene. GPNMB is highly expressed in [microglia](/cell-types/microglia), macrophages, osteoclasts, and melanocytes, where it functions as an anti-inflammatory receptor, phagocytosis mediator, and neuroprotective factor. In the context of neurodegeneration, GPNMB is strongly upregulated in disease-associated [microglia](/cell-types/microglia-neuroinflammation) (DAM) and lipid-laden microglia in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/amyotrophic-lateral-sclerosis). GPNMB is a top GWAS hit for PD risk, and its soluble ectodomain (sGPNMB) serves as both a cerebrospinal fluid biomarker and a neuroprotective signaling molecule.

<div class="infobox infobox-protein"> [@nalls2019]
<div class="infobox-header">GPNMB Protein</div> [@httenrauch2018]
<table> [@kerenshaul2017]
<tr><td class="infobox-label">Protein Name</td><td>Glycoprotein Nonmetastatic Melanoma Protein B</td></tr> [@zigdon2015]
<tr><td class="infobox-label">Gene</td><td><a href="/genes/gpnmb">GPNMB</a></td></tr> [@tanaka2012]
<tr><td class="infobox-label">UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/Q14956">Q14956</a></td></tr>
<tr><td class="infobox-label">PDB IDs</td><td><a href="https://www.rcsb.org/structure/7SJJ">7SJJ</a></td></tr>
<tr><td class="infobox-label">Molecular Weight</td><td>63.5 kDa (predicted), 90-120 kDa (glycosylated)</td></tr>
<tr><td class="infobox-label">Subcellular Localization</td><td>Cell surface, endosomes, lysosomes, melanosome-like organelles</td></tr>
<tr><td class="infobox-label">Protein Family</td><td>PMEL/NMB family (type I transmembrane glycoproteins)</td></tr>
<tr><td class="infobox-label">Associated Diseases</td><td><a href="/diseases/parkinsons-disease">PD</a>, <a href="/diseases/alzheimers-disease">AD</a>, <a href="/diseases/amyotrophic-lateral-sclerosis">ALS</a>, Gaucher disease</td></tr>
</table>
</div>

Structure

Domain Architecture

• Signal peptide (residues 1-22)
• Extracellular domain (residues 23-480): Contains the PKD (polycystic kidney disease) domain (residues 23-247) with RGD integrin-binding motif, and a heavily glycosylated mucin-like region (12 N-glycosylation sites)
• Transmembrane domain (residues 481-501): Single-pass alpha helix
• Cytoplasmic tail (residues 502-572): Contains a di-leucine endosomal sorting motif and a half ITIM (immunoreceptor tyrosine-based inhibitory motif)
• Soluble ectodomain (sGPNMB): Cleaved by [ADAM10](/genes/adam10) near the transmembrane domain; the shed ectodomain signals through CD44 and integrins

Post-Translational Modifications

• Heavy N-glycosylation: 12 N-linked glycans on the ectodomain; glycosylation patterns differ between cell types
• Proteolytic shedding: ADAM10 constitutive cleavage releases sGPNMB; regulated shedding is enhanced by inflammatory stimuli
• Lysosomal targeting: Di-leucine motif in the cytoplasmic tail directs GPNMB to late endosomes/lysosomes

Normal Function

Anti-Inflammatory Signaling

• Binds [CD44](/genes/cd44) on neighboring cells to suppress pro-inflammatory cytokine production
• Signals through the cytoplasmic ITIM-like motif to recruit SHP-1/SHP-2 phosphatases
• Downregulates [NF-κB](/entities/nf-kb) and MAPK signaling, reducing [TNF-α](/genes/tnf), [IL-6](/genes/il6), and [IL-1β](/genes/il1b) production
• sGPNMB acts as a paracrine neuroprotective factor by binding neuronal CD44 and integrins

Phagocytosis and Lipid Handling

• GPNMB promotes microglial phagocytosis of apoptotic [neurons](/entities/neurons), myelin debris, and [amyloid-beta](/proteins/amyloid-beta)
• Essential for lipid handling in lipid-laden microglia — GPNMB+ microglia efficiently process cholesterol-rich myelin debris
• GPNMB expression is strongly induced by lysosomal stress and lipid overload

Lysosomal Function

• Localizes to lysosomes and melanosome-like organelles
• Participates in lysosomal biogenesis; transcriptionally regulated by [TFEB](/genes/tfeb)/[TFE3](/genes/tfe3)
• Supports lysosomal membrane integrity under stress conditions

Role in Disease

Parkinson's Disease

• rs199347 (intronic variant) increases PD risk (OR ~1.1) by altering GPNMB expression
• GPNMB is massively upregulated in substantia nigra microglia in PD patients
• sGPNMB levels are elevated in PD CSF and correlate with disease severity
• [α-Synuclein](/proteins/alpha-synuclein) aggregates induce GPNMB in activated microglia
• sGPNMB promotes neuronal survival through ERK/AKT signaling
• [GBA1](/genes/gba1) mutations (Gaucher/PD overlap) drive lysosomal stress and GPNMB induction

Alzheimer's Disease

• GPNMB is a hallmark marker of disease-associated microglia (DAM) — the microglial phenotype found around amyloid plaques
• GPNMB+ microglia show enhanced phagocytic capacity but also contribute to chronic inflammation when overwhelmed
• sGPNMB levels are elevated in AD CSF and plasma
• GPNMB expression correlates with [TREM2](/genes/trem2) and [APOE](/genes/apoe) expression in plaque-associated microglia

ALS

• GPNMB is upregulated in spinal cord microglia of ALS patients and SOD1-G93A mice
• sGPNMB may serve as a CSF biomarker for microglial activation in ALS
• GPNMB promotes phagocytic clearance of motor neuron debris

Gaucher Disease

• [GBA1](/genes/gba1)-deficient macrophages massively upregulate GPNMB due to glucosylceramide accumulation
• GPNMB is one of the most elevated proteins in Gaucher disease serum
• The GBA1-GPNMB axis connects lysosomal storage disorders to PD risk

Therapeutic Targeting

• sGPNMB as a therapeutic: Recombinant sGPNMB ectodomain administration is neuroprotective in PD models
• Anti-GPNMB antibodies: Glembatumumab vedotin (CDX-011) targets GPNMB-expressing cells in cancer; repurposing for neuroinflammation is under investigation
• GPNMB as a biomarker: CSF and plasma sGPNMB levels track microglial activation and may serve as pharmacodynamic biomarkers for anti-inflammatory therapies

See Also

• [GPNMB Gene](/genes/gpnmb)
• [TREM2](/genes/trem2) — microglial activation receptor
• [Microglial Activation](/mechanisms/microglial-phagocytosis)
• [GBA1](/genes/gba1) — Gaucher/PD-linked lysosomal gene
• [Disease-Associated Microglia](/cell-types/microglia)

External Links

• [UniProt: Q14956](https://www.uniprot.org/uniprot/Q14956)
• [GeneCards: GPNMB](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPNMB)

References